KalVista Pharmaceuticals
KALV
KALV
82 hedge funds and large institutions have $303M invested in KalVista Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
16% less call options, than puts
Call options by funds: $5.6M | Put options by funds: $6.68M
Holders
82
Holding in Top 10
3
Calls
$5.6M
Puts
$6.68M
Top Buyers
| 1 | +$3.77M | |
| 2 | +$3.61M | |
| 3 | +$3.15M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$2.69M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.06M |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$2.85M | |
| 3 | -$2.62M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.92M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.9M |